INVITRIA
LIVE

Serial Number

88131104

Owner

INVITRIA, INC.

Attorney

Crissa A. Cook

First Use Date

Apr 17, 2007

Filing Date

Sep 25, 2018

Add to watchlist:

No watchlists yet
View on USPTO

INVITRIA Trademark

Serial Number: 88131104 • Registration: 5860458

INVITRIA is a trademark filed by INVITRIA, INC. on September 25, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

INVITRIA, INC. (31 trademarks)

2718 INDUSTRIAL DRIVE
JUNCTION CITY, KS 66441

Entity Type: 03

VENTRIA BIOSCIENCE INC. (47 trademarks)

2718 INDUSTRIAL DRIVE
JUNCTION CITY, KS 66441

Entity Type: 03

Trademark Details

Filing Date

September 25, 2018

Registration Date

September 17, 2019

First Use Anywhere

April 17, 2007

First Use in Commerce

April 17, 2007

Published for Opposition

July 2, 2019

Goods & Services

Cell culture media and cell culture media components for medical or veterinary use, namely for development of biopharmaceuticals, vaccines, gene therapies, cell therapies, and medical devices; pharmaceutical excipients, diluents for medical use, drug delivery agents in the form of diluents and coatings for tablets, capsules, particles, powders, and granules that facilitate the delivery of pharmaceutical and veterinary preparationsand drug delivery systems; blood product replacements and non-animal derived recombinant proteins for medical or veterinary use

Providing design and development of cell culture media and media components; research and development for others in the field of non-animal derived cell culture media and media components

Cell culture media and cell culture media components for scientific and research use, namely for development of biochemicals, cultured foods, life science research and development and tissue preservation; blood serum substitutes and serum proteins using non-animal manufacturing systems for use in the manufacture of pharmaceutical and veterinary preparations; blood product replacements and non-animal derived recombinant proteins for scientific and research use; Excipients for use in the manufacture of pharmaceutical preparations

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 10, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 10, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 3, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 25, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 17, 2024 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 13, 2023 ASGN
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 2, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 2, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 12, 2019 NONP
ASSIGNED TO LIE
May 29, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2018 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2018 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2018 CNRT
ASSIGNED TO EXAMINER
Dec 13, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2018 NWOS
NEW APPLICATION ENTERED
Sep 28, 2018 NWAP